The Efficacy and Safety of Low Dose versus Usual Dose of Hyoscine During Endoscopic Retrograde Cholangiopancreatography: A Randomized Clinical Trial

References

• Moutinho-RibeiroP, PeixotoA, MacedoG. Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: to be one traveler in converging roads. GE Portuguese J Gastroenterol. 2018;25(3):138–145. doi:10.1159/000481537
   Google Scholar
• AdlerDG, BaronTH, DavilaRE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62(1):1–8. doi:10.1016/j.gie.2005.04.01515990812
   PubMed Web of Science ®Google Scholar
• EarlyDS, Ben-MenachemT, DeckerGA, et al. Appropriate use of GI endoscopy. Gastrointest Endosc. 2012;75(6):1127–1131. doi:10.1016/j.gie.2012.01.01122624807
   PubMed Web of Science ®Google Scholar
• ChangF, GuoW, LiaoT, LeeS. A randomized study comparing glucagon and hyoscine N-butyl bromide before endoscopic retrograde cholangiopancreatography. Scand J Gastroenterol. 1995;30(3):283–286. doi:10.3109/003655295090932787539544
   PubMed Web of Science ®Google Scholar
• FroehlichJM, DaenzerM, von WeymarnC, ErturkSM, ZollikoferCL, PatakMA. Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol. 2009;19(6):1387–1393. doi:10.1007/s00330-008-1293-219190916
   PubMed Web of Science ®Google Scholar
• GutzeitA, BinkertCA, KohD-M, et al. Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration. Eur Radiol. 2012;22(6):1186–1194. doi:10.1007/s00330-011-2366-122270141
   PubMed Web of Science ®Google Scholar
• LahotiS, CatalanoMF, GeenenJE, HoganWJ. A prospective, double-blind trial of L-hyoscyamine versus glucagon for the inhibition of small intestinal motility during ERCP. Gastrointest Endosc. 1997;46(2):139–142. doi:10.1016/S0016-5107(97)70061-09283863
   PubMed Web of Science ®Google Scholar
• HanniganB, AxonA, AveryS, ThompsonR. Buscopan or glucagon for endoscopic cannulation of ampulla of vater?J R Soc Med. 1982;75(1):21.6173480
   PubMed Web of Science ®Google Scholar
• HashimotoT, AdachiK, IshimuraN, et al. Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy—a comparative study with butyl scopolamine bromide. Aliment Pharmacol Ther. 2002;16(1):111–118. doi:10.1046/j.1365-2036.2002.01148.x11856085
   PubMed Web of Science ®Google Scholar
• TytgatGN. Hyoscine butylbromide. Drugs. 2007;67(9):1343–1357. doi:10.2165/00003495-200767090-0000717547475
   PubMed Web of Science ®Google Scholar
• ChenG-L, HsuW-H. Hyoscine-N-Butyl-bromide-induced hypotension and myocardial ischemia. Case Rep Critical Care. 2013;2013:1–3. doi:10.1155/2013/414856
   Google Scholar
• SmithD, O’ConnellP. Cardiac dysrhythmias during oral surgery. Comparison of hyoscine and droperidol premedication. Anaesthesia. 1986;41(7):745–748. doi:10.1111/j.1365-2044.1986.tb12845.x3752438
   PubMed Web of Science ®Google Scholar
• GiesenH. Cardiac side-effects of oesophago-gastro-duodenoscopy in relation to premedication (author’s transl). Deutsche medizinische Wochenschrift (1946). 1978;103(39):1517–1520. doi:10.1055/s-0028-1129293688892
   PubMed Web of Science ®Google Scholar
• OzaslanE, KarakelleN, OzaslanNG. Hyoscine-N-butylbromide induced ventricular tachycardia during ERCP. J Anaesthesiol Clin Pharmacol. 2014;30(1):118. doi:10.4103/0970-9185.12573324574616
   PubMedGoogle Scholar
• JohnstonS, McKennaA, ThamT. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography. Endoscopy. 2003;35(12):1039–1042. doi:10.1055/s-2003-4459714648418
   PubMed Web of Science ®Google Scholar
• HanSJ, LeeTH, KangBI, et al. Efficacy and safety of therapeutic endoscopic retrograde cholangiopancreatography in the elderly over 80 years. Dig Dis Sci. 2016;61(7):2094–2101. doi:10.1007/s10620-016-4064-y26873537
   PubMed Web of Science ®Google Scholar
• RamsayM, SavegeT, SimpsonB, GoodwinR. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2(5920):656–659. doi:10.1136/bmj.2.5920.6564835444
   PubMed Web of Science ®Google Scholar
• DincB, GunduzUR, BasB, et al. The efficacy of intravenous hyoscine-N-butylbromide during colonoscopy: a prospective, randomized, double-blind, placebo-controlled study. Acta Gastroenterol Belg. 2016;79(2):179–185.27382934
   PubMed Web of Science ®Google Scholar
• MapleJT, Ben-MenachemT, AndersonMA, et al. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010;71(1):1–9. doi:10.1016/j.gie.2009.09.04120105473
   PubMed Web of Science ®Google Scholar
• BaronTH, MalleryJS, HirotaWK, et al. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest Endosc. 2003;58(5):643–649. doi:10.1016/S0016-5107(03)01994-114595292
   PubMed Web of Science ®Google Scholar
• ReddyDN, NabiZ, LakhtakiaS. How to improve cannulation rates during endoscopic retrograde cholangiopancreatography. Gastroenterology. 2017;152(6):1275–1279. doi:10.1053/j.gastro.2017.03.04128366733
   PubMed Web of Science ®Google Scholar
• KristoffersenMB, JPClausen. Bradycardia and hypotension during cyclopropane anaesthesia caused by hyoscine as premedication. BJA. 1967;39(7):578–584. doi:10.1093/bja/39.7.5786037375
   PubMedGoogle Scholar
• CasadeiB, PipilisA, SessaF, ConwayJ, SleightP. Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction. Circulation. 1993;88(2):353–357. doi:10.1161/01.CIR.88.2.3538339398
   PubMed Web of Science ®Google Scholar
• La RovereMT, MortaraA, PantaleoP, MaestriR, CobelliF, TavazziL. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation. 1994;90(2):838–843. doi:10.1161/01.CIR.90.2.8388044956
   PubMed Web of Science ®Google Scholar
• VenkateshG, FallenEL, KamathMV, ConnollyS, YusufS. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure. Heart. 1996;76(2):137–143. doi:10.1136/hrt.76.2.1378795476
   PubMed Web of Science ®Google Scholar
• ÖK, SevinçB, OkuşA, AyS, AksoyN. Otilonium bromide as spasmolytic during endoscopic retrograde cholangiopancreatography. Surg Endosc. 2015;29(8):2266–2269. doi:10.1007/s00464-014-3939-225361657
   PubMed Web of Science ®Google Scholar
• MaherR, Philips-HughesJ, BanningA, BoardmanP. The frequency and significance of silent myocardial ischemia due to hyoscine butylbromide use in peripheral angiography. Cardiovasc Intervent Radiol. 1999;22(5):369–374. doi:10.1007/s00270990040910501887
   PubMed Web of Science ®Google Scholar
• ChristensenM, MatzenP, SchulzeS, RosenbergJ. Complications of ERCP: a prospective study. Gastrointest Endosc. 2004;60(5):721–731. doi:10.1016/S0016-5107(04)02169-815557948
   PubMed Web of Science ®Google Scholar
• FisherL, FisherA, ThomsonA. Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc. 2006;63(7):948–955. doi:10.1016/j.gie.2005.09.02016733108
   PubMed Web of Science ®Google Scholar
• GlomsakerT, HoffG, KvaløyJ, et al. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg. 2013;100(3):373–380. doi:10.1002/bjs.899223225493
   PubMed Web of Science ®Google Scholar
• KounisN, ZavrasG, PapadakiP, et al. Electrocardiographic changes in elderly patients during endoscopic retrograde cholangiopancreatography. Can J Gastroenterol Hepatol. 2003;17(9):539–544.
   Google Scholar